You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Invagen Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for INVAGEN PHARMS, and what generic and branded alternatives to INVAGEN PHARMS drugs are available?

INVAGEN PHARMS has sixty-six approved drugs.

There is one tentative approval on INVAGEN PHARMS drugs.

Summary for Invagen Pharms

US Patents:	0
Tradenames:	54
Ingredients:	54
NDAs:	66

Drugs and US Patents for Invagen Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Invagen Pharms	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	078457-003	Aug 24, 2007		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Invagen Pharms	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	204414-001	May 5, 2014		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Invagen Pharms	SIMVASTATIN	simvastatin	TABLET;ORAL	206557-003	Nov 13, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Invagen Pharms	LISINOPRIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; lisinopril	TABLET;ORAL	204058-002	May 23, 2017	AB	RX	No	Yes		⤷ Subscribe				⤷ Subscribe
Invagen Pharms	LEVETIRACETAM	levetiracetam	TABLET;ORAL	078234-001	Jan 15, 2009		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Invagen Pharms	CYCLOBENZAPRINE HYDROCHLORIDE	cyclobenzaprine hydrochloride	TABLET;ORAL	090478-001	Jul 23, 2010	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Invagen Pharms	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET;ORAL	207389-002	Sep 18, 2017		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Invagen Pharms

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Invagen Pharms	LEUPROLIDE ACETATE FOR DEPOT SUSPENSION	leuprolide acetate	FOR SUSPENSION;INTRAMUSCULAR	205054-001	Aug 28, 2018	9,789,064	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.